117 related articles for article (PubMed ID: 2170591)
21. [Radiotherapy of glioblastoma: is shortening of the treatment time justifiable?].
Sautter-Bihl ML; Barcsay E; Liebermeister E; Winheller R; Liesegang J; Heinze HG
Strahlenther Onkol; 1991 Jan; 167(1):7-13. PubMed ID: 1846983
[TBL] [Abstract][Full Text] [Related]
22. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
Sneed PK; Stauffer PR; McDermott MW; Diederich CJ; Lamborn KR; Prados MD; Chang S; Weaver KA; Spry L; Malec MK; Lamb SA; Voss B; Davis RL; Wara WM; Larson DA; Phillips TL; Gutin PH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):287-95. PubMed ID: 9457811
[TBL] [Abstract][Full Text] [Related]
23. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.
Videtic GM; Gaspar LE; Zamorano L; Stitt LW; Fontanesi J; Levin KJ
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):963-8. PubMed ID: 11704318
[TBL] [Abstract][Full Text] [Related]
24. Continuous hyperfractionated accelerated radiotherapy in the treatment of high-grade astrocytomas.
Beşe NS; Uzel O; Turkan S; Okkan S
Radiother Oncol; 1998 May; 47(2):197-200. PubMed ID: 9683369
[TBL] [Abstract][Full Text] [Related]
25. Radiation response and survival time in patients with glioblastoma multiforme.
Barker FG; Prados MD; Chang SM; Gutin PH; Lamborn KR; Larson DA; Malec MK; McDermott MW; Sneed PK; Wara WM; Wilson CB
J Neurosurg; 1996 Mar; 84(3):442-8. PubMed ID: 8609556
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM).
Witteler J; Schild SE; Rades D
Anticancer Res; 2020 Dec; 40(12):7025-7030. PubMed ID: 33288598
[TBL] [Abstract][Full Text] [Related]
27. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
[TBL] [Abstract][Full Text] [Related]
28. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.
Langer CJ; Ruffer J; Rhodes H; Paulus R; Murray K; Movsas B; Curran W
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):113-9. PubMed ID: 11516860
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy.
Mizumoto M; Yamamoto T; Takano S; Ishikawa E; Matsumura A; Ishikawa H; Okumura T; Sakurai H; Miyatake S; Tsuboi K
Pract Radiat Oncol; 2015; 5(1):e9-16. PubMed ID: 25413424
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
31. Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.
Clarke JW; Chang EL; Levin VA; Mayr NA; Hong E; Cavaliere R; Lo SS
Expert Rev Anticancer Ther; 2008 May; 8(5):733-41. PubMed ID: 18471046
[TBL] [Abstract][Full Text] [Related]
32. Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.
Slotman BJ; Kralendonk JH; van Alphen HA; Kamphorst W; Karim AB
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):895-8. PubMed ID: 8598367
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.
Chang EL; Yi W; Allen PK; Levin VA; Sawaya RE; Maor MH
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):519-28. PubMed ID: 12738329
[TBL] [Abstract][Full Text] [Related]
35. Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.
Brada M; Sharpe G; Rajan B; Britton J; Wilkins PR; Guerrero D; Hines F; Traish D; Ashley S
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):287-92. PubMed ID: 10030251
[TBL] [Abstract][Full Text] [Related]
36. Treatment of glioblastoma multiforme. A review.
Caldwell WL; Aristizabal SA
Acta Radiol Ther Phys Biol; 1975 Dec; 14(6):505-12. PubMed ID: 178151
[TBL] [Abstract][Full Text] [Related]
37. Accelerated hyperfractionated radiotherapy for malignant gliomas.
Buatti JM; Marcus RB; Mendenhall WM; Friedman WA; Bova FJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):785-92. PubMed ID: 8598354
[TBL] [Abstract][Full Text] [Related]
38. Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Souhami L; Panet-Raymond V; Petrecca K; Owen S; Guiot MC; Patyka M; Sabri S; Shenouda G; Abdulkarim B
Radiat Oncol; 2015 Apr; 10():106. PubMed ID: 25927334
[TBL] [Abstract][Full Text] [Related]
39. High dose tamoxifen and radiotherapy in patients with glioblastoma multiforme: a phase IB study.
Muanza T; Shenouda G; Souhami L; Leblanc R; Mohr G; Corns R; Langleben A
Can J Neurol Sci; 2000 Nov; 27(4):302-6. PubMed ID: 11097520
[TBL] [Abstract][Full Text] [Related]
40. [Results of local radiotherapy and modified total-brain irradiation in astrocytoma].
Fritz P; Becker F; Kuttig H; zum Winkel K
Strahlenther Onkol; 1989 Aug; 165(8):571-7. PubMed ID: 2549649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
